TY  - GEN
AU  - Signoriello,E
AU  - Lanzillo,R
AU  - Brescia Morra,V
AU  - Di Iorio,G
AU  - Fratta,M
AU  - Carotenuto,A
AU  - Lus,G
TI  - Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis
SN  - 1477-0970
PY  - 2018///0129
KW  - Adult
KW  - Female
KW  - Humans
KW  - Immunosuppressive Agents
KW  - adverse effects
KW  - Leukocyte Count
KW  - Lymphocytosis
KW  - blood
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Multiple Sclerosis, Chronic Progressive
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - Natalizumab
KW  - Predictive Value of Tests
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Time Factors
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1177/1352458515604381
ER  -